ISCD Learning
Catalog Advanced Search
-
Both ACCME and ASRT Credits
Expires 9/14/2027: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) is a complex disorder of bone and mineral metabolism that affects all patients with CKD, in particular as kidney dysfunction worsens. CKD-MBD is associated with abnormalities in the Vitamin D-Parathyroid axis and Osteoporosis. This session will review the epidemiology of CKD-MBD and its complications and strategies to diagnose and manage the disorder, with a focus on patient-centered outcomes.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.00 ASRT Category A Credits
Activity Expires September 14, 2027Activity Description
Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) is a complex disorder of bone and mineral metabolism that affects all patients with CKD, in particular as kidney dysfunction worsens. CKD-MBD is associated with abnormalities in the Vitamin D-Parathyroid axis and Osteoporosis. This session will review the epidemiology of CKD-MBD and its complications and strategies to diagnose and manage the disorder, with a focus on patient-centered outcomes.
Learning Objectives:
- Appreciate new definition of CKD-MBD
- Understand CKD-MBD from a patient-oriented perspective
- Learn a basic treatment approached to CKD-MBD
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.00 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
Thomas L. Nickolas, MD, MS, FASN, FASBMR
Chief, David C. and Betty Farrell Professor of Medicine
Division of Bone and Mineral Diseases, Washington University School of Medicine
Dr. Nickolas is a Professor of Medicine and Chief of the Division of Bone and Mineral Diseases at the Washington University School of Medicine in St Louis. Dr. Nickolas received his medical degree from the University of Pittsburgh School of Medicine, trained in Internal Medicine at the University of Pennsylvania and in Nephrology at Columbia University. His primary interests are in the skeletal effects of kidney diseases. His lab focuses on redefining our understanding of and approach to bone disease in adults and children with kidney failure. He uses advanced and novel methods to phenotype the characteristics of bone and mineral diseases in CKD patients.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 10/1/2027: This session will introduce DXA technologists to emerging innovations that are shaping the future of bone densitometry, with an emphasis on artificial intelligence–enabled tools and data integration. Participants will examine how AI-driven quality-control processes and automated region-of-interest detection can enhance measurement consistency, workflow efficiency, and scalability across clinical settings. The program will also examine how DXA data can be linked with large clinical and research datasets to support advanced risk prediction, longitudinal monitoring, and population-level analysis. In addition, participants will discuss key research opportunities and critical knowledge gaps that must be addressed to advance next-generation DXA technologies and inform the evolving role of the DXA technologist.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 1, 2027Activity Description
This session will introduce DXA technologists to emerging innovations that are shaping the future of bone densitometry, with an emphasis on artificial intelligence–enabled tools and data integration. Participants will examine how AI-driven quality-control processes and automated region-of-interest detection can enhance measurement consistency, workflow efficiency, and scalability across clinical settings. The program will also examine how DXA data can be linked with large clinical and research datasets to support advanced risk prediction, longitudinal monitoring, and population-level analysis. In addition, participants will discuss key research opportunities and critical knowledge gaps that must be addressed to advance next-generation DXA technologies and inform the evolving role of the DXA technologist.
Learning Objectives
- Recognize how AI-enabled quality control and automated region-of-interest detection can improve consistency, efficiency, and scalability of DXA measurements.
- Identify how DXA data can be linked with large clinical and research datasets to support risk prediction, longitudinal monitoring, and population-level analysis.
- Identify key research opportunities and critical gaps that must be addressed to advance the next generation of bone densitometry.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
John A. Shepherd, PhD, FAAPM, CCD
Professor/Chief Scientific Officer
University of Hawaii Cancer Center, Honolulu, HI
Dr. Shepherd is a Researcher/Professor at the University of Hawaii Cancer Center, a Fulbright Scholar, a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and a former President of the International Society for Clinical Densitometry. He received his PhD in Engineering Physics from the University of Virginia and then completed a Postdoctoral Fellowship in Biophysics at Princeton University. From there he went on to develop body composition and bone density algorithms for a major women’s health company and his patents are the basis for the accuracy of that company’s body composition algorithms. He then joined the Radiology Department of the University of California San Francisco and led his own research group for 19 years studying a wide variety of biomarkers for breast cancer, obesity and osteoporosis from medical imaging using advanced machine learning techniques. For the past 5 years, he has been with the University of Hawaii Cancer Center and is currently their Chief Scientific Officer. He also directs the UH Artificial Intelligence Precision Health Institute and the Hawaii Pacific Islands Mammography Registry. He has been continuously funded from the NIH since 2005, led 6 R01-funded studies, published over 350 peer-review publications that have been referenced over 23,000 times, and lastly is an avid surfer and island ridge hiker!
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 9/14/2027: This session will provide an overview of fractures from a radiology perspective. Real life cases will be shown. The imaging modalities covered include radiographs, MRI, and CT. The second lecture lecture reviews orthopedic surgical management of common fractures in patients with metabolic bone disease, using case examples of atypical femur fractures and osteoporotic pelvic ring injuries. The session emphasizes timely recognition, referral for operative evaluation, and surgical strategies that support mobilization and reduce risk of fracture progression or future injury.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires September 14, 2027Activity Description
This session will provide an overview of fractures from a radiology perspective. Real life cases will be shown. The imaging modalities covered include radiographs, MRI, and CT. The second lecture lecture reviews orthopedic surgical management of common fractures in patients with metabolic bone disease, using case examples of atypical femur fractures and osteoporotic pelvic ring injuries. The session emphasizes timely recognition, referral for operative evaluation, and surgical strategies that support mobilization and reduce risk of fracture progression or future injury.
Learning Objectives
- Define stress fracture and identify common locations
- Understand the role of XR, CT, MRI, and bone scintigraphy
- Apply an evidence-based imaging algorithm for stress fracture evaluation
- Recognize atypical femur fractures in patients with metabolic bone disease, including key radiographic features, risk factors, and the importance of imaging the contralateral femur
- Identify when orthopedic referral or prophylactic fixation should be considered, particularly for incomplete or contralateral atypical femur fractures with symptoms or radiographic abnormalities
- Describe the evaluation and operative management considerations for osteoporotic pelvic ring injuries, including U-type sacral fractures, instability patterns, pain as a marker of instability, and the role of percutaneous screw fixation to improve mobilization
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
Erwin E. Xia, MD, CCD
Attending Radiologist
Hospital for Special Surgery
Erwin E. Xia, MD is an Attending Radiologist at Hospital for Special Surgery and Assistant Professor of Radiology at Weill Medical College of Cornell University. He completed his fellowship in Musculoskeletal Imaging and Intervention at Massachusetts General Hospital, Harvard Medical School and residency in Diagnostic Radiology at Thomas Jefferson University Hospital. His clinical interests include image-guided spine and joint interventional procedures, orthopedic sports imaging, and orthopedic oncology.
Kathryn Barth, MD
Trauma Surgeon
Hospital for Special Surgery
Dr. Kathryn Barth is an orthopedic surgeon specializing in the treatment of fractures in the upper and lower extremities, pelvis, and acetabulum. She has expertise in both operative and non-operative management of complex peri-articular fractures and post-traumatic problems such as deformity and non-unions (non-healing fractures).
Dr. Barth graduated summa cum laude from the University of Pennsylvania while graduating with honors in her major in Health & Societies: Health Care Markets & Finance and completing premedical requirements. She attended the Northwestern Feinberg School of Medicine in Chicago, IL where she graduated summa cum laude and was awarded the Clare Geigerich Award for Outstanding Promise in Orthopaedic Surgery. She was also inducted into the Alpha Omega Alpha Honors Society. She went on to complete her residency training in orthopedic surgery at the Hospital for Special Surgery where she served in leadership roles and received the Distinguished Housestaff Award upon graduation. She then completed a year-long fellowship at the University of Texas Health Science Center at Houston, one of the top training programs for orthopaedic trauma surgery in the country. She has also spent time abroad during her training learning about the reconstruction of complex traumatic injuries and non-unions at the Royal Brisbane & Women's Hospital in Australia and Korea University Guru Hospital in Seoul, South Korea.
Dr. Barth is also passionate about improving the care of trauma patients through clinical outcomes research. She has authored multiple peer-reviewed publications and presented research at numerous national research meetings. She is an active member of the American Academy of Orthopaedic Surgeons (AAOS) and the Orthopaedic Trauma Association (OTA).
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 9/14/2027: The session will focus on imaging findings of metabolic and genetic disorders of childhood that affect bone mineral density. The session will review the impact of growth on the manifestation of metabolic disorders, and how these disorders affect bone formation. The session will also discuss the diagnosis by imaging of complications that can arise from abnormal bone metabolism in children.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires September 14, 2027Activity Description
The session will focus on imaging findings of metabolic and genetic disorders of childhood that affect bone mineral density. The session will review the impact of growth on the manifestation of metabolic disorders, and how these disorders affect bone formation. The session will also discuss the diagnosis by imaging of complications that can arise from abnormal bone metabolism in children.
All images within the presentation are provided as a courtesy by Dr. Diego Jaramillo, MD, MPH, FACR
Learning Objectives
- Describe the key anatomic and imaging features of pediatric metabolic bone disease, including the roles of the physis, zone of provisional calcification, metaphysis, epiphysis, and periosteum in endochondral and intramembranous ossification.
- Differentiate common pediatric metabolic bone disorders on imaging, including rickets, renal osteodystrophy, hypophosphatasia, scurvy, osteogenesis imperfecta, lead toxicity, osteopetrosis, Gaucher disease, and mucopolysaccharidoses.
- Apply radiographic patterns to clinical diagnosis and management considerations, including recognizing disease distribution, distinguishing metabolic bone disease from trauma or non-accidental injury, and minimizing radiation exposure during pediatric imaging.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
Diego Jaramillo, MD, MPH, FACR
Attending Radiologist
Hospital for Special Surgery
Dr. Jaramillo is a pediatric radiologist specialized in imaging musculoskeletal disorders in children. He began his career as a pediatric radiologist at Massachusetts General Hospital and Boston Children’s Hospital at Harvard Medical School. From 2004 to 2015 he was Radiologist-in-Chief and Van Alen Chair of Radiology at The Children’s Hospital of Philadelphia and Professor of Radiology at the University of Pennsylvania School of Medicine. He has been a Vice Chair of Radiology at Stanford University and the Interim Chair of Radiology at Columbia University. He is currently the Director of Pediatric Imaging at the Hospital for Special Surgery and a Professor of Radiology at the Weill Cornell College of Medicine. He has been the President and Board Chair of the Society for Pediatric Radiology. His research has focused on the study of growth disorders using novel imaging technologies, mainly MRI-based, with both basic and transIational approaches. He has been the principal investigator of 3 major grants from the NIH. His current research focuses on studies of skeletal growth using diffusion tensor imaging of the physeal cartilage and newly formed metaphyseal bone, a technique he developed. He has published more than 170 peer reviewed publications and more than 100 reviews, chapters and case reports.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 9/1/2027: This session will provide an in-depth, technologist-focused review of DXA acquisition and analysis variability across manufacturers, with emphasis on accurate region-of-interest (ROI) placement and interpretation for spine and hip examinations. Participants will examine common sources of technologist error, including suboptimal patient positioning, inappropriate post-acquisition analysis adjustments, and incorrect scan mode selection, and will learn strategies to prevent these pitfalls. The session will underscore the critical role of immediate scan review while the patient remains present, particularly for ensuring correct bone mapping and diagnostic integrity. In addition, participants will explore challenges related to serial comparability and review manufacturer-specific software glitches that may impact longitudinal bone density assessment.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires September 1, 2027Activity Description
This session will provide an in-depth, technologist-focused review of DXA acquisition and analysis variability across manufacturers, with emphasis on accurate region-of-interest (ROI) placement and interpretation for spine and hip examinations. Participants will examine common sources of technologist error, including suboptimal patient positioning, inappropriate post-acquisition analysis adjustments, and incorrect scan mode selection, and will learn strategies to prevent these pitfalls. The session will underscore the critical role of immediate scan review while the patient remains present, particularly for ensuring correct bone mapping and diagnostic integrity. In addition, participants will explore challenges related to serial comparability and review manufacturer-specific software glitches that may impact longitudinal bone density assessment.
Learning Objectives
- Compare manufacturer-specific differences in region-of-interest (ROI) placement and analysis for spine and hip scans.
- Explain sources of technologist error including pitfalls of poor-quality positioning, inappropriate adjustments to the scan analysis, and improper scan mode selection.
- Recognize the importance of immediate scan review while the patient is present especially in the context of appropriate bone mapping.
- Describe serial comparability challenges and manufacturer-specific glitches.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on August 15th, 2026.
Wendy Tolman-Andrews, BS, RT(BD), CBDT
Radiologic Technologist
University of Connecticut - Farmington campus at UConn Health
Wendy Tolman-Andrews, BS, RT(BD), CBDT has been performing DXA bone densitometry since 1997. She’s a longtime active member of the ISCD on various committees and workgroups recently as part of “Ask an Expert”, Facility Accreditation, Patient Resources, and Strategic Planning. She is honored to have received the Sydney Bonnick Award, ISCD Technologist of the Year, and the Paul D. Miller Service Award. Wendy currently works at the University of Connecticut’s Farmington campus at UConn Health.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 9/1/2027: This educational session will provide a practical overview of current pharmacologic options for the prevention and treatment of osteoporosis. Participants will review commonly used bone medications and gain a clear understanding of how these therapies differ in their mechanisms of action on bone remodeling. The program will also address expected changes in bone mineral density associated with various treatments, including realistic timelines for achieving clinically meaningful improvement, to support informed decision-making and patient counseling.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires September 1, 2027Activity Description
This educational session will provide a practical overview of current pharmacologic options for the prevention and treatment of osteoporosis. Participants will review commonly used bone medications and gain a clear understanding of how these therapies differ in their mechanisms of action on bone remodeling. The program will also address expected changes in bone mineral density associated with various treatments, including realistic timelines for achieving clinically meaningful improvement, to support informed decision-making and patient counseling.
Learning Objectives
- List current bone medications used for osteoporosis prevention and treatment.
- Differentiate the mechanisms of action of these medications on bone.
- Describe expected bone density changes and the time intervals required to observe clinically meaningful improvement.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on August 15th, 2026.
E. Michael Lewiecki, MD, FACP, FACE, CCD
Director
New Mexico Clinical Research & Osteoporosis Center, Inc.
E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 8/14/2027: While much of our clinical focus is the diagnosis and management of osteoporosis, it is important to recognize the characteristic imaging features of other causes of decreased or increased bone mineral density, pathologic fracture, and other disorders that may mimic osteoporosis. This talk reviews the spectrum of imaging findings of common (and some uncommon) metabolic bone diseases, differential diagnosis, and pearls and pitfalls for accurate diagnosis. Examples of delayed or missed diagnosis will be highlighted.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires August 14, 2027Activity Description
While much of our clinical focus is the diagnosis and management of osteoporosis, it is important to recognize the characteristic imaging features of other causes of decreased or increased bone mineral density, pathologic fracture, and other disorders that may mimic osteoporosis. This talk reviews the spectrum of imaging findings of common (and some uncommon) metabolic bone diseases, differential diagnosis, and pearls and pitfalls for accurate diagnosis. Examples of delayed or missed diagnosis will be highlighted.
Learning Objectives
- Recognize the imaging features and limitations of osteoporosis evaluation, including the role of DXA, radiographs, CT, MRI, and the importance of reviewing images rather than relying only on numeric bone density results.
- Develop a differential diagnosis for abnormal bone density, including causes of increased bone density such as Paget disease, osteoblastic metastases, myelofibrosis, fluorosis, renal osteodystrophy, and osteopetrosis, as well as causes of decreased bone density such as osteomalacia, hyperparathyroidism, malignancy, osteogenesis imperfecta, and steroid-related bone loss.
- Identify metabolic bone disease mimics and high-risk diagnoses that should not be missed, including pathologic compression fractures, multiple myeloma, osteoid osteoma, occult osteoporotic hip fractures, hypertrophic osteoarthropathy, and hemorrhagic soft tissue sarcoma.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on August 15th, 2026.
Kevin R. Math, MD
Associate Attending Radiologist
Hospital for Special Surgery
Dr. Kevin Math is a musculoskeletal radiologist at the Hospital for Special Surgery in NYC, primarily involved with imaging of bone, joint and soft tissue pathology and injuries. His main clinical focus is imaging of metabolic bone disease in addition imaging of sports injuries, joint replacements and performing musculoskeletal interventional procedures. He is the Director of Bone Densitometry and routinely utilizes DXA and other imaging modalities for diagnosis of metabolic bone disease and assisting clinicians in the care of their patients.
Dr. Math is an Associate Professor of Radiology at the Weill Medical College of Cornell University and is also very involved with resident and fellow education at his hospital.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 8/14/2027: This talk explores how AI can transform opportunistic imaging, mining routinely acquired imaging studies, to detect low bone density and identify patients at risk for osteoporosis without additional costs or radiation. The end-to-end pipeline from algorithm development and external validation to workflow integration and reporting, highlighting performance, calibration, and generalizability across sites and scanners will be discussed. Real-world case studies will illustrate clinical impact on fracture risk stratification and care pathways and implementation logistics.
Activity approved for 0.75 AMA PRA Category 1 Credits™
Activity approved for 1.00 ASRT Category A Credits
Activity Expires August 14, 2027Activity Description
This talk explores how AI can transform opportunistic imaging, mining routinely acquired imaging studies, to detect low bone density and identify patients at risk for osteoporosis without additional costs or radiation. The end-to-end pipeline from algorithm development and external validation to workflow integration and reporting, highlighting performance, calibration, and generalizability across sites and scanners will be discussed. Real-world case studies will illustrate clinical impact on fracture risk stratification and care pathways and implementation logistics.
Learning Objectives
- Define opportunistic imaging
- Describe CT-based bone density evolution
- Identify technical factors affecting CT BMD
- Evaluate AI applications
- Assess disparities and population impact
- Describe factors affecting clinical benefits of opportunistic imaging
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.00 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on August 15th, 2026.
Miriam A. Bredella, MD, MBA
Bernard and Irene Schwartz Professor of Radiology & Vice Chair for Strategy
NYU Langone Health and NYU Grossman School of Medicine
Dr. Bredella is Associate Dean for Translational Science and Director and Principle Investigator of the NIH-funded Clinical and Translational Science Institute at NYU Langone Health. She is also a musculoskeletal radiologist and the Bernard and Irene Schwartz Professor of Radiology at the NYU Grossman School of Medicine and vice chair for strategy in the Department of Radiology at NYU. She holds an MBA from MIT/Sloan School of Management.
Dr. Bredella is an NIH-funded physician scientist focusing on novel functional imaging techniques to determine the effects of body composition and different fat depots on bone and cardiometabolic risk with a special focus on sex differences. She has advanced the adoption of opportunistic imaging, repurposing CT scans performed for routine clinical care, to evaluate bone health into clinical practice. Dr. Bredella is the author of over 300 peer-reviewed manuscripts and multiple textbooks. She is a Scholar in Diagnostic Excellence of the National Academy of Medicine and a Fellow of the American College of Radiology. She is the recipient of multiple awards, including the Distinguished Investigator Award from the Academy of Radiology Research and the Presidents Medal of the International Skeletal Society.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 7/14/2027: This talk will examine the role of DXA in diagnosing sarcopenia, highlighting its accessibility and value for estimating lean mass in clinical and research settings. It will critically discuss key limitations, including variability across devices, cut-off definitions, and the inability of DXA to capture muscle mass, quality and function. Practical implications for clinicians will be addressed, with guidance on how to interpret DXA findings within a comprehensive sarcopenia assessment. The second talk reviews the clinical application of bone turnover markers in osteoporosis management, with emphasis on monitoring response to oral bisphosphonate therapy. The lecture explains practical approaches for interpreting CTX, P1NP, and other markers to assess adherence, identify responders, and guide treatment decisions during and after therapy.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires July 14, 2027Activity Description
This talk will examine the role of DXA in diagnosing sarcopenia, highlighting its accessibility and value for estimating lean mass in clinical and research settings. It will critically discuss key limitations, including variability across devices, cut-off definitions, and the inability of DXA to capture muscle mass, quality and function. Practical implications for clinicians will be addressed, with guidance on how to interpret DXA findings within a comprehensive sarcopenia assessment. The second talk reviews the clinical application of bone turnover markers in osteoporosis management, with emphasis on monitoring response to oral bisphosphonate therapy. The lecture explains practical approaches for interpreting CTX, P1NP, and other markers to assess adherence, identify responders, and guide treatment decisions during and after therapy.
Learning Objectives:
- Differentiate sarcopenia as a disease from normal age-related changes in lean mass.
- Evaluate the clinical usefulness and limitations of DXA for assessing lean mass in suspected sarcopenia and osteosarcopenia.
- Describe emerging approaches and consensus efforts for defining and diagnosing sarcopenia, including the role of muscle mass, strength, and outcomes.
- Identify key sources of variability in bone turnover marker testing, including circadian rhythm, food intake, age, sex, and recent fracture.
- Apply least significant change and reference targets to determine whether a patient is responding to osteoporosis therapy.
- Use bone turnover markers to monitor adherence, treatment response, and offset of effect after oral bisphosphonate therapy.
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on July 15th, 2026.
Gustavo Duque, MD, PhD, FRACP, FGSA
Professor of Medicine and Director of the Division of Geriatric Medicine
McGill University
Dr. Gustavo Duque, MD, PhD, FRACP, is a geriatrician and biomedical scientist with a research interest in the mechanisms, potential therapies, and biomarkers for age-related bone loss, osteoporosis, sarcopenia, osteosarcopenia, and frailty in older persons. He also studies the effects of vitamin D, exercise, and protein intake on bone and muscle mass.
His initial training included Internal Medicine at Javeriana University (Colombia) and Geriatric Medicine, which he completed at McGill University in Montreal (Canada). He obtained his PhD at McGill University in 2003 with a thesis entitled “Molecular Changes of the Aging Osteoblast” under the supervision of Dr. Richard Kremer. Between 2003 and November 2007, he joined the McGill University Medical School faculty as a member of the Division of Geriatric Medicine and as a Researcher at the Lady Davis Institute for Medical Research.
In November 2007, he moved to Australia to join the faculty as Associate Professor and Head of the Division of Geriatric Medicine and Director of the Musculoskeletal Ageing Research Program at Sydney Medical School Nepean, University of Sydney. In 2012, he was promoted to Professor of Medicine at the University of Sydney. Between 2015 and 2022, Dr. Duque held the positions of Chair of Medicine and Director of the Australian Institute for Musculoskeletal Science at the University of Melbourne.
In 2022, Dr. Duque assumed the roles of Full Professor, Dr. Joseph Kaufmann Chair in Geriatric Medicine, Director of the RUISSS McGill Centre of Excellence for Sustainable Health of Seniors/Simone & Edouard Shouela (CEDurable), and Principal Investigator in the Bone, Muscle & Geroscience Group at the Research Institute of the McGill University Health Centre (MUHC). He is also the Editor-in-Chief of the Journal of Gerontology: Biological Sciences, one of the official journals of the Gerontological Society of America. In 2025, he became Director of the McGill Division of Geriatric Medicine.
As a geriatrician and clinician-investigator, Dr. Duque has implemented several Falls and Fractures clinics—including the most recent at the McGill University Health Centre and the Jewish General Hospital in Montreal—where patients are comprehensively assessed for fall and fracture risk. His clinical trials unit conducts multiple studies evaluating pharmacological and non-pharmacological therapies for age-related musculoskeletal diseases. He is the author of more than 360 peer-reviewed articles and multiple book chapters and has edited five books in the aging and musculoskeletal fields, including two on osteosarcopenia.
Richard Eastell, MD
Professor and Head of the Academic Unit of Bone Metabolism
University of Sheffield
Dr. Richard Eastell is a Professor and Head of the Academic Unit of Bone Metabolism at the University of Sheffield–Sheffield Teaching Hospitals NHS Trust and Director of the Mellanby Centre for Bone Research in Sheffield, UK. He is an internationally recognized expert in osteoporosis, bone metabolism, and bone turnover markers.
Professor Eastell holds several prestigious positions including National Institute for Health Research Senior Investigator Emeritus status and serves on the International Osteoporosis Foundation Committee of Scientific Advisors. He has held leadership roles with the European Calcified Tissue Society (Program Co-Chair), serves as Treasurer for IBMS, and sits on editorial boards for Endocrine Reviews and Lancet Diabetes and Endocrinology. He also serves as Senior Editor for the journal Bone.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 8/1/2027: This session will provide DXA technologists with an overview of less commonly used DXA features and companion technologies that extend the clinical utility of standard bone density testing. Participants will review specialized DXA features including vertebral fracture assessment (VFA), full femur imaging (FFI), lateral distal femur (LDF) imaging, and orthopedic applications, with emphasis on utility, indications, acquisition techniques and analysis. The program will also address performance of additional DXA-derived analyses such as FRAX and hip geometry, highlighting technologist responsibilities in data accuracy and workflow integration. In addition, participants will explore the role of DXA companion software—including trabecular bone score (TBS) and 3D Shaper to better understand their technical requirements, outputs, and clinical relevance in comprehensive skeletal assessment.
Activity approved for 2.00 ASRT Category A Credits
Activity Expires August 1, 2027Activity Description
This session will provide DXA technologists with an overview of less commonly used DXA features and companion technologies that extend the clinical utility of standard bone density testing. Participants will review specialized DXA features including vertebral fracture assessment (VFA), full femur imaging (FFI), lateral distal femur (LDF) imaging, and orthopedic applications, with emphasis on utility, indications, acquisition techniques and analysis. The program will also address performance of additional DXA-derived analyses such as FRAX and hip geometry, highlighting technologist responsibilities in data accuracy and workflow integration. In addition, participants will explore the role of DXA companion software—including trabecular bone score (TBS) and 3D Shaper to better understand their technical requirements, outputs, and clinical relevance in comprehensive skeletal assessment.
Learning Objectives
- Describe enhanced DXA features, including vertebral fracture assessment (VFA), full femur imaging (FFI), lateral distal femur (LDF), and orthopedic hip protocols.
- Perform additional analyses derived from DXA scans, including FRAX and hip geometry.
- Discuss the utility of DXA companion software, including trabecular bone score (TBS) and 3D Shaper.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 2.00 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on July 15th, 2026.
Diane Krueger, BS, CCRC, CBDT
Researcher
Osteoporosis Clinical Research Program - University of Wisconsin, Madison
Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993 and researcher since 2021. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 100 manuscripts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Committee in addition to the Annual Meeting Committee. In her leadership capacity, she has served as Education Council chair, Executive Committee and Board. Additionally, she held several officer positions including Secretary and four Presidential seats.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
